2. Academic Validation
  3. Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptor

Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptor

  • ACS Chem Neurosci. 2014 Oct 15;5(10):902-7. doi: 10.1021/cn500173x.
Briana J Davie 1,  Patrick M Sexton,  Ben Capuano,  Arthur Christopoulos,  Peter J Scammells
Affiliations

Affiliation

  • 1 Medicinal Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
PMID: 25188871 DOI: 10.1021/cn500173x
Abstract

The field of G protein-coupled receptor drug discovery has benefited greatly from the structural and functional insights afforded by photoactivatable ligands. One G protein-coupled receptor subfamily for which photoactivatable ligands have been developed is the Muscarinic Acetylcholine Receptor family, though, to date, all such ligands have been designed to target the orthosteric (endogenous ligand) binding site of these receptors. Herein we report the synthesis and pharmacological investigation of a novel photoaffinity label, MIPS1455 (4), designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor; a target of therapeutic interest for the treatment of cognitive deficits. MIPS1455 may be a valuable molecular tool for further investigating allosteric interactions at this receptor.

Keywords

BQCA; Muscarinic; allosteric; cognition; photoactivatable; photoaffinity.

Figures
Products